Sustained baculovirus-mediated expression in myogenic cells

Journal of Gene Medicine

Volumn 10, Issue 11, 2008, Pages 1190-1197

  Shen, Heng Chun ^a   Yeh, Chia Ni ^a   Chen, Guan Yu ^a   Huang, Shiu Feng ^b   Chen, Chi Yuan ^a   Chiu, Yung Chung ^c,d   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Baculovirus; C2C12; Gene transfer; Long term; Sustained transgene expression

Indexed keywords

BACULOVIRUS VECTOR; DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; RNA; ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL DIFFERENTIATION; CELL LINE; CYTOMEGALOVIRUS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; HELA CELL; HUMAN; HUMAN CELL; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BACULOVIRUS; CELL CULTURE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETICS; METABOLISM; METHODOLOGY; TRANSGENE;

CYTOMEGALOVIRUS; MAMMALIA;

ANIMALS; BACULOVIRIDAE; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; FLOW CYTOMETRY; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MICE; MYOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 58149198787     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1245     Document Type: Article

References (43)

1. Hu Y-C. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008; 8: 54-65.
2. Hu Y-C. Baculovirus vectors for gene therapy. Adv Virus Res 2006; 68: 287-320.
3. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23: 567-575.
4. Airenne KJ, Hiltunen MO, Turunen MP, et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 2000; 7: 1499-1504.
5. Boyce FM, Bucher NLR. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-2352.
6. Condreay JP, Witherspoon SM, Clay WC, et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127-132.
7. Duisit G, Saleun S, Douthe S, et al. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J Gene Med 1999; 1: 93-102.
8. Wang C-Y, Wang S. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Hum Gene Ther 2005; 16: 1219-1226.
9. Condreay JP, Ames RS, Hassan NJ, et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 2006; 68: 255-286.
10. Kost TA, Condreay JP, Ames RS, et al. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 2007; 12: 396-403.
11. Kaikkonen MU, Raty JK, Airenne KJ, et al. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 2006; 13: 304-312.
12. Makela AR, Oker-Blom C. Baculovirus display: a multifunctional technology for gene delivery and eukaryotic library development. Adv Virus Res 2006; 68: 91-112.
13. van Oers MM. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res 2006; 68: 193-253.
14. Hu Y-C, Yao K, Wu T-Y. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 2008; 7: 363-371.
15. Lesch HP, Turpeinen S, Niskanen EA, et al. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 2008; May 8 [Epub ahead of print].
16. Huang K-S, Lo W-H, Chung Y-C, et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 2007; 18: 1161-1170.
17. Wang C-Y, Li F, Yang Y, et al. Recombinant baculovirus containing the Diphtheria toxin A gene for malignant glioma therapy. Cancer Res 2006; 66: 5798-5806.
18. Zeng J, Du J, Zhao Y, et al. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007; 25: 1055-1061.
19. Ho Y-C, Lee H-P, Hwang S-M, et al. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther 2006; 13: 1471-1479.
20. Chen H-C, Sung L-Y, Lo W-H, et al. Combination of baculovirus-mediated BMP-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther 2008; 15: 309-317.
21. Chuang C-K, Sung L-Y, Hwang S-M, et al. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther 2007; 14: 1417-1424.
22. Wang K-C, Wu J-C, Chung Y-C, et al. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 2005; 89: 464-473.
23. Svensson EC, Tripathy SK, Leiden JM. Muscle-based gene therapy: Realistic possibilities for the future. Mol Med Today 1996; 2: 166-172.
24. Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991; 254: 1507-1509.
25. Dhawan J, Pan LC, Pavlath GK, et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 1991; 254: 1509-1512.
26. Partridge TA, Morgan JE, Coulton GR, et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337: 176-179.
27. Wolff JA, Ludtke JJ, Acsadi G, et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1: 363-369.
28. Rando TA, Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994; 125: 1275-1287.
29. Hu YC, Tsai CT, Chang YJ, et al. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: Focuses on strategic infection and feeding. Biotechnol Prog 2003; 19: 373-379.
30. Shen H-C, Lee H-P, Lo W-H, et al. Baculovirus-mediated gene transfer is attenuated by sodium bicarbonate. J Gene Med 2007; 9: 470-478.
31. Ho Y-C, Chung Y-C, Hwang S-M, et al. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 2005; 7: 860-868.
32. Palombo F, Monciotti A, Recchia A, et al. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol 1998; 72: 5025-5034.
33. Duan D, Yan Z, Yue Y, et al. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J Virol 2001; 75: 7662-7671.
34. Acsadi G, Jani A, Huard J, et al. Cultured human myoblasts and myotubes show markedly different transducibilty by replication defective adenovirus recombinant. Gene Ther 1994; 1: 338-340.
35. Dai Y, Roman M, Naviaux RK, et al. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1992; 89: 10892-10895.
36. Liu CM, Bahnson AB, Dunigan JT, et al. Long-term expression and secretion of human glucocerebrosidase by primary murine and human myoblasts and differentiated myotubes. J Mol Med 1998; 76: 773-781.
37. Hortelano G, Wang L, Xu N, et al. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis. Haemophilia 2001; 7: 207-214.
38. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 2001; 12: 871-881.
39. Abe T, Takahashi H, Hamazaki H, et al. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003; 171: 1133-1139.
40. Yang D-G, Chung Y-C, Lai Y-K, et al. Avian influenza virus hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties and vaccine potential. Mol Ther 2007; 15: 989-996.
41. Strauss R, Huser A, Ni S, et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007; 15: 193-202.
42. Goncalves MAFV, Swildens J, Holkers M, et al. Genetic complementation of human muscle cells via directed stem cell fusion. Mol Ther 2008; 16: 741-748.
43. Baum C. What are the consequences of the fourth case? Mol Ther 2007; 15: 1401-1402.